Delivery Order SPE2DB22D3102-SPE2DB25FL3BB
- Not listed
- The Defense Logistics Agency awarded a $2,393.28 delivery order to AmerisourceBergen Drug Corp for Methylergonovine 0.2 mg/mL, a pharmaceutical product used in obstetric care. The contract utilizes firm fixed pricing with an ultimate completion date of September 15, 2025, and carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is a...
- The Defense Logistics Agency awarded a $1,602.15 delivery order to AmerisourceBergen Drug Corp for Methylergonovine 0.2 mg/mL on September 16, 2025, with completion scheduled for September 17, 2025. This firm fixed price delivery order represents a competitive award with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract procures a pharmaceutical product used in obstetric care to prevent and treat postpartum...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Methylergonovine 0.2 mg/mL injection vials, with a firm fixed price of $1,355.56 and an ultimate completion date of September 16, 2025. This non-competitive delivery order represents a single-transaction pharmaceutical procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Methylergonovine 0.2 mg tablets (28-count) with a firm fixed price ceiling value of $1,547.44. The contract was competitively awarded with no set-aside designation and is scheduled for ultimate completion on August 22, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,794.96 to AmerisourceBergen Drug Corp for the supply of Methylergonovine 0.2 mg/mL, a pharmaceutical product used in obstetric care. This firm fixed price, non-set-aside contract was awarded on July 25, 2025, with an ultimate completion date of July 28, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a time-sensitive procurement for a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Methylergonovine 0.2 mg/mL in ampule form, with a firm fixed price ceiling value of $2,015.40 and an ultimate completion date of August 29, 2025. This competitively awarded, non-set-aside contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Methylergonovine 0.2 mg/ml in ampule form, valued at $3,170.91 with a firm fixed price arrangement. The contract is unclassified as a set-aside and was awarded on August 3, 2025, with an ultimate completion date of August 4, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on May 1, 2025, for the supply of Methylergonovine 0.2 mg tablets (12-count packaging) with a ceiling value of $2,410.20. This is a firm fixed-price delivery order with an ultimate completion date of May 2, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Methylergonovine 0.2 mg tablets in quantities of 12 units, with a ceiling value of $1,209.92. This is a firm fixed price delivery order with an ultimate completion date of July 30, 2025, and represents a non-set-aside competitive award. The contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Methylergonovine 0.2 mg tablets in unit dose packages of 20, with a ceiling value of $11,136.19. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 15, 2025, and will be performed at the awardee's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting open competition among...
- SPE2DB22D3102Indefinite Delivery Contract
- SPE2DB22D3102-SPE2DB25FL3BBDelivery Order
The Defense Logistics Agency awarded a $2,847.08 delivery order to AmerisourceBergen Drug Corp for Methylergonovine 0.2 mg/mL on September 16, 2025, with an ultimate completion date of September 17, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal medical supply vendor, particularly for military and veteran healthcare systems. This delivery order represents a routine pharmaceutical procurement supporting DLA's medical supply chain, which leverages the company's comprehensive IDC vehicle to fulfill diverse pharmaceutical and medical supply requirements across the Department of Defense healthcare infrastructure. The prime vendor relationship enables AmerisourceBergen to deliver a broad range of specialty medications, generic drugs, and medical commodities to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 9/16/25 |